Literature DB >> 16085672

Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox).

John Q Liu1, Igor N Zelko, Efua M Erbynn, James S K Sham, Rodney J Folz.   

Abstract

Chronic exposure to low-O2 tension induces pulmonary arterial hypertension (PAH), which is characterized by vascular remodeling and enhanced vasoreactivity. Recent evidence suggests that reactive oxygen species (ROS) may be involved in both processes. In this study, we critically examine the role superoxide and NADPH oxidase plays in the development of chronic hypoxic PAH. Chronic hypoxia (CH; 10% O2 for 3 wk) caused a significant increase in superoxide production in intrapulmonary arteries (IPA) of wild-type (WT) mice as measured by lucigenin-enhanced chemiluminescence. The CH-induced increase in the generation of ROS was obliterated in NADPH oxidase (gp91phox) knockout (KO) mice, suggesting that NADPH oxidase was the major source of ROS. Importantly, pathological changes associated with CH-induced PAH (mean right ventricular pressure, medial wall thickening of small pulmonary arteries, and right heart hypertrophy) were completely abolished in NADPH oxidase (gp91phox) KO mice. CH potentiated vasoconstrictor responses of isolated IPAs to both 5-hydroxytryptamine (5-HT) and the thromboxane mimetic U-46619. Administration of CuZn superoxide dismutase to isolated IPA significantly reduced CH-enhanced superoxide levels and reduced the CH-enhanced vasoconstriction to 5-HT and U-46619. Additionally, CH-enhanced superoxide production and vasoconstrictor activity seen in WT IPAs were markedly reduced in IPAs isolated from NADPH oxidase (gp91phox) KO mice. These results demonstrate a pivotal role for gp91phox-dependent superoxide production in the pathogenesis of CH-induced PAH.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085672     DOI: 10.1152/ajplung.00135.2005

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  139 in total

Review 1.  PPARgamma as a potential therapeutic target in pulmonary hypertension.

Authors:  Roy L Sutliff; Bum-Yong Kang; C Michael Hart
Journal:  Ther Adv Respir Dis       Date:  2010-06       Impact factor: 4.031

Review 2.  Reactive oxygen and nitrogen species in pulmonary hypertension.

Authors:  Diana M Tabima; Sheila Frizzell; Mark T Gladwin
Journal:  Free Radic Biol Med       Date:  2012-03-06       Impact factor: 7.376

3.  Pulmonary arterial responses to reactive oxygen species are altered in newborn piglets with chronic hypoxia-induced pulmonary hypertension.

Authors:  Candice D Fike; Judy L Aschner; James C Slaughter; Mark R Kaplowitz; Yongmei Zhang; Sandra L Pfister
Journal:  Pediatr Res       Date:  2011-08       Impact factor: 3.756

4.  Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosis.

Authors:  Arnold S Kristof; Zhipeng You; Yin-Shan Han; Adel Giaid
Journal:  Peptides       Date:  2010-04-28       Impact factor: 3.750

5.  Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene.

Authors:  Chun Zhang; Jun-Jun Hu; Min Xia; Krishna M Boini; Christopher A Brimson; Laura A Laperle; Pin-Lan Li
Journal:  Free Radic Biol Med       Date:  2010-01-29       Impact factor: 7.376

6.  Role of Nox2 in diabetic kidney disease.

Authors:  Young-Hyun You; Shinichi Okada; San Ly; Karin Jandeleit-Dahm; David Barit; Tamehachi Namikoshi; Kumar Sharma
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

7.  The role of NADPH oxidase in chronic intermittent hypoxia-induced pulmonary hypertension in mice.

Authors:  Rachel E Nisbet; Anitra S Graves; Dean J Kleinhenz; Heidi L Rupnow; Alana L Reed; Tai-Hwang M Fan; Patrick O Mitchell; Roy L Sutliff; C Michael Hart
Journal:  Am J Respir Cell Mol Biol       Date:  2008-10-23       Impact factor: 6.914

Review 8.  NADPH oxidases in lung health and disease.

Authors:  Karen Bernard; Louise Hecker; Tracy R Luckhardt; Guangjie Cheng; Victor J Thannickal
Journal:  Antioxid Redox Signal       Date:  2014-01-03       Impact factor: 8.401

9.  Hypoxia-induced oxidative base modifications in the VEGF hypoxia-response element are associated with transcriptionally active nucleosomes.

Authors:  Mykhaylo V Ruchko; Olena M Gorodnya; Viktor M Pastukh; Brad M Swiger; Natavia S Middleton; Glenn L Wilson; Mark N Gillespie
Journal:  Free Radic Biol Med       Date:  2008-10-18       Impact factor: 7.376

10.  Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.

Authors:  Revathi Rajkumar; Kazuhisa Konishi; Thomas J Richards; David C Ishizawar; Andrew C Wiechert; Naftali Kaminski; Ferhaan Ahmad
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-01-15       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.